ViaDerma, Inc.
OTC: VDRM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christopher A Otiko
- Employees
- 75
- Headquarters
- Marina del Rey, United States
- IPO year
- 2014
- Market cap
- $493.5K
- Website
- https://viadermalicensing.com
Loading VDRM…
Loading profile data…Frequently asked questions about VDRM
What does ViaDerma, Inc. (VDRM) do?
ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a to...
Where does VDRM trade?
ViaDerma, Inc. (VDRM) trades on the Other OTC.
What sector is VDRM in?
ViaDerma, Inc. (VDRM) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ViaDerma, Inc.?
Christopher A Otiko is the chief executive officer of ViaDerma, Inc. (VDRM).
Where is ViaDerma, Inc. headquartered?
ViaDerma, Inc. is headquartered in United States.
Does VDRM pay a dividend?
ViaDerma, Inc. (VDRM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VDRM go public?
ViaDerma, Inc. (VDRM) completed its initial public offering in 2014.